Danyelle Townsend to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications Danyelle Townsend has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.041
-
Pharmacology of ME-344, a novel cytotoxic isoflavone. Adv Cancer Res. 2019; 142:187-207.
Score: 0.041
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.